Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
Recruiting now
Conditions studied: Correction Vision Surgery, Cataract Surgery
In brief
Millions of people have undergone laser vision correction surgery and are motivated to continue with spectacle independence as they develop presbyopia (gradual loss of your eyes' ability to focus on nearby objects)and cataract. However, having a history of refractive surgery, poses challenges in the selection of the IOLs and can lead to visual outcomes that are unpredictable. Data from an international registry and single prospective study show that Vivity IOL provided effective distance, intermediate and near vision in eyes with previous LASIK with minimal effects on day vision associated with the surgery. The purpose of this study is to evaluate the clinical outcomes of post-myopic refractive surgery patients implanted with the Clareon Vivity/Vivity Toric lenses
Key facts
- Study ID
- NCT06924944
- Run by
- Utah Eye Centers
- People needed
- 35
- Starts
- 2025-01-20
- Expected to finish
- 2026-04-01
- Last updated by the study team
- 2025-04-13
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- o Bilateral age-related visually significant cataracts in otherwise healthy eyes, undergoing uncomplicated bilateral sequential Clareon Vivity IOLs
- Prior history of uncomplicated post-refractive myopic surgery (LASIK/PRK) with up to 1 enhancement treatment
- Potential acuity measured post-operatively 20/25 or better in both eyes
- Patients with regular astigmatism that can be managed with T3 toric lens or arcuate incision
You may not qualify if…
- o Ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, etc.
- Prior ocular surgeries other than uncomplicated corneal refractive surgery and excluding RK
- Patients with irregular astigmatism/topography (to rule out signs of potential ectasia), corneal dystrophies, and pupil abnormalities
- Total HOA cutoff of ≤0.5, coma ≤0.3
- RLE patients
Where it is running
- Utah Eye Centers — Ogden, Utah, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.